This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.Find sources: "Beatrice" psychedelic – news · newspapers · books · scholar · JSTOR (July 2019)
Beatrice
Beatrice (psychedelic).png
Beatrice-3d-sticks.png
Names
Preferred IUPAC name
1-(2,5-Dimethoxy-4-methylphenyl)-N-methylpropan-2-amine
Other names
4-Methyl-2,5-dimethoxy-methamphetamine
2-(4-Methyl-2,5-dimethoxyphenyl)ethan-alpha,N-methylamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C13H21NO2/c1-9-6-13(16-5)11(7-10(2)14-3)8-12(9)15-4/h6,8,10,14H,7H2,1-5H3 checkY
    Key: IWYGVDBZCSCJGT-UHFFFAOYSA-N checkY
  • O(c1cc(c(OC)cc1CC(NC)C)C)C
Properties
C13H21NO2
Molar mass 223.316 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Beatrice (also known as MDO-D, MDOM, Béa and 4-methyl-2,5-dimethoxymethamphetamine) is a lesser-known psychedelic drug. It is a substituted methamphetamine and a homolog of 2,5-dimethoxy-4-methylamphetamine (DOM). Beatrice was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 30 mg, and the duration listed as 6–10 hours.[1] Beatrice produces a vague feeling of openness and receptiveness, and causes a stimulative effect. It also causes diarrhea. Very little data exists about the pharmacological properties, metabolism, and toxicity of beatrice.

See also

References